Erythromycin thiocyanate (CAS No 7704-67-8) is a macrolide antibiotic used in biomedical research primarily focused on its antibacterial properties Originating from the bacterium Saccharopolyspora erythraea its mechanism of action involves inhibiting bacterial protein synthesis by binding to the 50S ribosomal subunit thereby preventing the growth of certain bacteria This compound exhibits in vitro activity typically in the nanomolar to low micromolar range making it effective in research models Erythromycin thiocyanate finds applications in various cell models and animal studies often used in drug screening and testing due to its well-documented antibacterial spectrum Experimental concentrations typically depend on the specific research design Its use in studies helps elucidate the cellular pathways of resistance and supports the development of novel therapeutic strategies to combat bacterial infections